Toxic Epidermal Necrolysis Lawsuit

AboutLawsuits

Add Your Comments

Toxic Epidermal Necrolysis Syndrome, which is also known as TEN or Lyell’s Syndrome, is a potentially fatal skin reaction which could be caused by a number of different medications. It is a more severe form of Stevens-Johnson Syndrome.

TOXIC EPIDERMAL NECROLSIS LITIGATION: Potential cases are reviewed by Toxic Epidermal Necrolysis lawyers throughout the United States. If a medication does not provide proper warnings about the possible Stevens-Johnson syndrome or toxic epidermal necrolysis side effects, users who experience problems may be entitled to compensation.

<p align="center">>REVIEW A POTENTIAL TEN LAWSUIT WITH A LAWYER<<

Do You Know about…

Spinal Cord Stimulator lawsuits

Spinal cord stimulator lawsuits are being investigated for individuals who suffered unnecessary shocks, burns or other problems, often resulting in the need for additional surgery to remove the SCS.

Learn More
SEE IF YOU QUALIFY FOR COMPENSATION
Spinal-Cord-Stimulation-Lawsuit
Spinal-Cord-Stimulation-Lawsuit

Do You Know About…

Spinal Cord Stimulator lawsuits

Spinal cord stimulator lawsuits are being investigated for individuals who suffered unnecessary shocks, burns or other problems, often resulting in the need for additional surgery to remove the SCS.

Learn More
SEE IF YOU QUALIFY FOR COMPENSATION

OVERVIEW: Toxic Epidermal Necrolysis is a more severe form of the skin reaction known as Stevens-Johnson Syndrome. When skin lesions cover more than 30% of the body, a diagnosis of Toxic Epidermal Necrolysis is usually clinically made.

TEN causes the top layer of skin to detach from the lower layers.

For More Information See: Stevens-Johnson Syndrome Lawsuits

Tags: TEN, Toxic Epidermal Necrolysis

More Lawsuit Stories

3 Comments

Sandi
I underwent a stem cell transplant in January of 2007 for a very rare kidney disease. During the process I was given Allopurinol and, as a result, suffered a severe episode of TENS in March. I was in the burn unit for a number of weeks. Thereafter, in September, I was given another antibiotic from the cephlosporin family and suffered a second episode of TENS and was placed back in the burn unit for another couple of weeks..
Stevens Johnson Syndrome Linked to Dilantin, Phenytek and Cerebyx : AboutLawsuits.com
[…] increased risk of suffering from a severe skin reaction known as Stevens-Johnson Syndrome (SJS) or Toxic Epidermal Necrolysis (TEN), after taking the epilepsy drugs Dilantin, Phenytek or Cerebyx.   Stevens-Johnson Syndrome, which […]
Revlimid Stevens-Johnson Syndrome Warning Could be Added : AboutLawsuits.com
[…] According to drug maker Celgen Corp., the FDA will likely update the warning label for their blood-cancer drug Revlimid to indicate that side effects of the medication could lead to potentially fatal skin reactions such as Stevens-Johnson syndrome (SJS) or toxic epidermal necrolysis (TEN). […]

This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

Apple AirTag Stalking Lawsuits Consolidated in Northern District of California
Dozens of Apple AirTag stalking lawsuits have been centralized in the U.S. District Court for the Northern District of California for coordinated discovery and pretrial proceedings.
DraftKings AI Lawsuit Alleges Gambling Promotions Targeted Users Likely to Lose Money
A class action lawsuit against DraftKings claims it uses AI to encourage gambling addiction in consumers.
Covidien ProGrip Mesh Lawsuit Scheduled for March 2027 Jury Trial
A federal judge has selected the third claim to serve as a Covidien hernia mesh bellwether trial, which will begin in March.